SOURCE: Market Foundations Inc.

June 07, 2012 09:00 ET

Where Opportunity is Found - Research & Analysis on Eaton Vance Corp and Hospira, Inc.

HONG KONG--(Marketwire - Jun 7, 2012) - This morning, www.MarketFoundations.com announced new reports highlighting Eaton Vance Corp (NYSE: EV) and Hospira, Inc. (NYSE: HSP). Free research downloads are available at www.MarketFoundations.com/index.php?coa=EV&cob=HSP.

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential - there remains strong opportunity within careful discretion.

Market Foundations is releasing new coverage on Eaton Vance Corp for its current position within the financial industry. Eaton Vance Corp. is engaged in managing investment funds and providing investment management and counseling services to high-net-worth individuals and institutions. The Company focuses to develop and sustain management expertise across a range of investment disciplines and to offer investment products and services through multiple distribution channels. The full research report on Eaton Vance Corp (NYSE: EV) is available here: www.MarketFoundations.com/index.php?coa=EV.

Market Foundations has released research on Hospira, Inc. for its changing role within the healthcare industry. Hospira, Inc. (Hospira) is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. The full research report on Hospira, Inc. (NYSE: HSP) is available here: www.MarketFoundations.com/index.php?cob=HSP.

About Market Foundations
By providing members with financial information services, we provide the foundation investors need to build investing intelligence. The difference between consistently making good investments or bad investments is nothing more than the right information at the right time.

Contact Information